However, for netrin-1 therapeutic utility, cautions should be taken as induction of netrin-1 expression via NF-κB in inflammatory bowel disease has been reported to affect colorectal tumor promotion and progression, and is also associated with worse outcome in poorly differentiated pancreatic adenocarcinomas [44], [45]. Here, NFKB1 is linked to pancreatic adenocarcinoma.